Literature DB >> 23623418

Effect of anchoring 4-anilidopiperidines to opioid peptides.

Ravil R Petrov1, Yeon Sun Lee, Ruben S Vardanyan, Lu Liu, Shou-wu Ma, Peg Davis, Josephine Lai, Frank Porreca, Todd W Vanderah, Victor J Hruby.   

Abstract

We report here the design, synthesis, and in vitro characterization of new opioid peptides featuring a 4-anilidopiperidine moiety. Despite the fact that the chemical structures of fentanyl surrogates have been found suboptimal per se for the opioid activity, the corresponding conjugates with opioid peptides displayed potent opioid activity. These studies shed an instructive light on the strategies and potential therapeutic values of anchoring the 4-anilidopiperidine scaffold to different classes of opioid peptides.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623418      PMCID: PMC3942532          DOI: 10.1016/j.bmcl.2013.03.065

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.

Authors:  F D Lung; J P Meyer; B S Lou; L Xiang; G Li; P Davis; I A DeLeon; H I Yamamura; F Porreca; V J Hruby
Journal:  J Med Chem       Date:  1996-06-21       Impact factor: 7.446

2.  Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.

Authors:  Hong-Mei Liu; Xue-Feng Liu; Jin-Long Yao; Chang-Lin Wang; Ye Yu; Rui Wang
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

3.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity.

Authors:  Ravil R Petrov; Ruben S Vardanyan; Yeon S Lee; Shou-wu Ma; Peg Davis; Lucinda J Begay; Josephine Y Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2006-07-07       Impact factor: 2.823

5.  Antinociceptive profile of biphalin, a dimeric enkephalin analog.

Authors:  P J Horan; A Mattia; E J Bilsky; S Weber; T P Davis; H I Yamamura; E Malatynska; S M Appleyard; J Slaninova; A Misicka
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

6.  Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.

Authors:  P J Emmerson; M R Liu; J H Woods; F Medzihradsky
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

7.  Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.

Authors:  V Erspamer; P Melchiorri; G Falconieri-Erspamer; L Negri; R Corsi; C Severini; D Barra; M Simmaco; G Kreil
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Ravil Petrov; Chad K Park; Shou-wu Ma; Peg Davis; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  J Med Chem       Date:  2007-10-10       Impact factor: 7.446

9.  Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration.

Authors:  Carrie L Wade; Daniel J Schuster; Kristine M Domingo; Kelley F Kitto; Carolyn A Fairbanks
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

10.  Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.

Authors:  K R Snyder; S C Story; M E Heidt; T F Murray; G E DeLander; J V Aldrich
Journal:  J Med Chem       Date:  1992-11-13       Impact factor: 7.446

View more
  1 in total

1.  Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.

Authors:  Srinivas Deekonda; Lauren Wugalter; Vinod Kulkarni; David Rankin; Tally M Largent-Milnes; Peg Davis; Neemah M Bassirirad; Josephine Lai; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-08-04       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.